# Gencyte Therapeutics Inc.

Canonical: https://abierto.us/vendors/gencyte-therapeutics-inc-klltvaecbmn8

- UEI: KLLTVAECBMN8
- CAGE: 7ZVP4
- Location: San Carlos, CA
- Awards in window: 2 (5 transactions), $499,990 obligated, February 26, 2024 to July 16, 2026

## Awarding agencies

- National Institutes of Health: 2 awards, $499,990

## Industries

- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology): $499,990

## Competition

- Full and Open Competition After Exclusion of Sources: 2 awards

## Largest awards

- 75N91025C00046 (definitive contract): $499,990, NIH NCI. Phase I SBIR Concept Award for Logic Gated Molecular Adaptor System for JMML Treatment. https://www.usaspending.gov/award/CONT_AWD_75N91025C00046_7529_-NONE-_-NONE-/
- 75N91023C00014 (definitive contract): $0, NIH NCI. The Purpose of This Modification Is to Extend the Period of Performance from February 26, 2024 to August 26, 2024. https://www.usaspending.gov/award/CONT_AWD_75N91023C00014_7529_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/gencyte-therapeutics-inc-klltvaecbmn8.